Harbor Capital Advisors’s iTeos Therapeutics ITOS Stock Holding History

Harbor Capital Advisors’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-148	Closed	-$1K	–	1418
2025 Q2	$1K	Sell	148 -522	-78%	-$4.21K	﹤0.01%	1359
2025 Q1	$4K	Buy	670 +347	+107%	+$2.55K	﹤0.01%	1242
2024 Q4	$2K	Sell	323 -5	-2%	-$43	﹤0.01%	1277
2024 Q3	$3K	Buy	+328	New	+$5K	﹤0.01%	1228

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbor Capital Advisors's ITOS Position: Q3 2025 in Review

Harbor Capital Advisors sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 148 shares — an estimated $1K sold.

Harbor Capital Advisors first reported a position in ITOS in Q3 2024 and held it in 4 quarters. The position peaked at $4K in Q1 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Harbor Capital Advisors reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Harbor Capital Advisors sold 148 iTeos Therapeutics shares in Q3 2025, an estimated $1K.
Harbor Capital Advisors first reported a position in iTeos Therapeutics in Q3 2024 and held it in 4 quarters.
Harbor Capital Advisors's iTeos Therapeutics position peaked at $4K in Q1 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Harbor Capital Advisors's 13F filing for Q3 2025, filed 15 Oct 2025.